To analyze the efficacy, tolerability, toxicity profile, quality of life and pharmaco-economics of adjuvant TAC compared to FAC regimen in hormone receptor-positive breast cancer with more than four involved lymph nodes
2007
11043 Aim: To analyze the efficacy, tolerability, toxicity profile, quality of life, survival rates and pharmaco-economics of TAC vs. FAC in women with ER/PR positive breast cancer and >4 involved ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI